Compositions and uses thereof for the treatment of chronic feline respiratory disorders
A technology for respiratory diseases and compositions, applied in the direction of respiratory diseases, drug combinations, antiviral agents, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0075] Example 1 - Preparation of Veterinary Compositions
[0076] Veterinary compositions were prepared by mixing the following components as shown in Table 1 below
[0077] Table 1:
[0078]
[0079] QSP 100g with Isopar V (solvent)
[0080] The diffuser used is as described in the design patent US D752’730S
[0081] Diffusers are available for areas from 20 to 70m 2 in the room. The refill contains 48ml of Feliway product and will release the product over 20 to 30 days.
Embodiment 2
[0083] The study described here was designed to determine the Kittens with experimentally induced FHV-1 infection in the equivalent room of a diffuser or a placebo diffuser and subjected to stress caused by a change of residence did not perform well in terms of behavioral scores, clinical scores, FHV-1 shedding, or serum cortisol concentrations. There are different.
[0084] Materials and methods
[0085] cat. Six castrated male and six neutered female 5-month-old purpose-bred kittens were used in this 12-week pilot study. Eight weeks prior to the study described here, each of 12 kittens were infected with FHV-1 by intranasal instillation for use in the study, in which 12 kittens were the control group. For the purposes of this new study, these kittens were reused without having to experimentally revaccinate other cats. In this study, all kittens had confirmed FHV-1 infection, and each kitten presented with a clinical presentation consisting of fever, sneezing, ocular and...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


